Delirium, Dementia, Amnestic, Cognitive Disorders  >>  etazolate (SQ-20009)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
etazolate (SQ-20009) / Eurobio Scientific
NCT00880412 / 2007-005549-39: A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease

Completed
2a
197
Europe
EHT 0202 etazolate, EHT 0202, etazolate, Placebo
Exonhit
Alzheimer's Disease
06/09
08/09

Download Options